Non-alcoholic fatty liver disease risk factors: Difference between revisions
Jump to navigation
Jump to search
| Line 17: | Line 17: | ||
**Obesity | **Obesity | ||
**Hypopituitarism | **Hypopituitarism | ||
** | **Diabetes mellitus type 2 | ||
**PCOS (Polycystic ovarian syndrome) | **PCOS (Polycystic ovarian syndrome) | ||
Revision as of 03:07, 18 December 2017
|
Non-Alcoholic Fatty Liver Disease Microchapters |
|
Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case studies |
|
Non-alcoholic fatty liver disease risk factors On the Web |
|
American Roentgen Ray Society Images of Non-alcoholic fatty liver disease risk factors |
|
Directions to Hospitals Treating Non-alcoholic fatty liver disease |
|
Risk calculators and risk factors for Non-alcoholic fatty liver disease risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
Overview
The most potent risk factor in the development of NAFLD is obesity. Other risk factors include insulin resistence and metabolic syndrome.
Risk Factors
- Risk factors in the development of Non-alcoholic fatty liver disease include:[1][2][3]
- Medications like Tamoxifen ,corticosteriods , methotrexate
- Viral Hepatitis.
- Rapid weight loss.
- Malnutrition.
- High levels of triglyceride in blood.
- Sleep apnea
- Hypothyroid
- Obesity
- Hypopituitarism
- Diabetes mellitus type 2
- PCOS (Polycystic ovarian syndrome)
References
- ↑ Streba LA, Vere CC, Rogoveanu I, Streba CT (2015). "Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question". World J Gastroenterol. 21 (14): 4103–10. doi:10.3748/wjg.v21.i14.4103. PMC 4394070. PMID 25892859.
- ↑ He S, Bao W, Shao M, Wang W, Wang C, Sun J; et al. (2011). "Risk factors for non-alcoholic fatty liver disease in a Chinese population". Acta Gastroenterol Belg. 74 (4): 503–8. PMID 22319959.
- ↑ Streba LA, Vere CC, Rogoveanu I, Streba CT (2015). "Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question". World J. Gastroenterol. 21 (14): 4103–10. doi:10.3748/wjg.v21.i14.4103. PMC 4394070. PMID 25892859.